205 related articles for article (PubMed ID: 24220136)
1. What difference a decade? The costs of psychosis in Australia in 2000 and 2010: comparative results from the first and second Australian national surveys of psychosis.
Neil AL; Carr VJ; Mihalopoulos C; Mackinnon A; Lewin TJ; Morgan VA
Aust N Z J Psychiatry; 2014 Mar; 48(3):237-48. PubMed ID: 24220136
[TBL] [Abstract][Full Text] [Related]
2. Costs of psychosis in 2010: findings from the second Australian National Survey of Psychosis.
Neil AL; Carr VJ; Mihalopoulos C; Mackinnon A; Morgan VA
Aust N Z J Psychiatry; 2014 Feb; 48(2):169-82. PubMed ID: 24097844
[TBL] [Abstract][Full Text] [Related]
3. Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study.
Carr VJ; Neil AL; Halpin SA; Holmes S; Lewin TJ
Aust N Z J Psychiatry; 2003 Feb; 37(1):31-40. PubMed ID: 12534654
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
5. Cost of high prevalence mental disorders: Findings from the 2007 Australian National Survey of Mental Health and Wellbeing.
Lee YC; Chatterton ML; Magnus A; Mohebbi M; Le LK; Mihalopoulos C
Aust N Z J Psychiatry; 2017 Dec; 51(12):1198-1211. PubMed ID: 28565923
[TBL] [Abstract][Full Text] [Related]
6. People living with psychotic illness in 2010: the second Australian national survey of psychosis.
Morgan VA; Waterreus A; Jablensky A; Mackinnon A; McGrath JJ; Carr V; Bush R; Castle D; Cohen M; Harvey C; Galletly C; Stain HJ; Neil AL; McGorry P; Hocking B; Shah S; Saw S
Aust N Z J Psychiatry; 2012 Aug; 46(8):735-52. PubMed ID: 22696547
[TBL] [Abstract][Full Text] [Related]
7. Estimating the Cost and Effect of Early Intervention on In-Patient Admission in First Episode Psychosis.
Behan C; Cullinan J; Kennelly B; Turner N; Owens E; Lau A; Kinsella A; Clarke M
J Ment Health Policy Econ; 2015 Jun; 18(2):57-61. PubMed ID: 26231001
[TBL] [Abstract][Full Text] [Related]
8. Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian National Survey of Psychosis.
Stain HJ; Galletly CA; Clark S; Wilson J; Killen EA; Anthes L; Campbell LE; Hanlon MC; Harvey C
Aust N Z J Psychiatry; 2012 Sep; 46(9):879-89. PubMed ID: 22645395
[TBL] [Abstract][Full Text] [Related]
9. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
[TBL] [Abstract][Full Text] [Related]
10. An Economic Evaluation of Coordinated Specialty Care (CSC) Services for First-Episode Psychosis in the U.S. Public Sector.
Murphy SM; Kucukgoncu S; Bao Y; Li F; Tek C; Breitborde NJK; Guloksuz S; Phutane VH; Ozkan B; Pollard JM; Cahill JD; Woods SW; Cole RA; Schoenbaum M; Srihari VH
J Ment Health Policy Econ; 2018 Sep; 21(3):123-130. PubMed ID: 30530872
[TBL] [Abstract][Full Text] [Related]
11. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
Ezenduka C; Ichoku H; Ochonma O
J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of multiple sclerosis in Australia in 2010.
Palmer AJ; Colman S; O'Leary B; Taylor BV; Simmons RD
Mult Scler; 2013 Oct; 19(12):1640-6. PubMed ID: 23652216
[TBL] [Abstract][Full Text] [Related]
13. Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry.
Ademi Z; Liew D; Hollingsworth B; Steg PG; Bhatt DL; Reid CM;
Am J Cardiovasc Drugs; 2010; 10(2):85-94. PubMed ID: 20334445
[TBL] [Abstract][Full Text] [Related]
14. The societal cost of schizophrenia in Sweden.
Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
[TBL] [Abstract][Full Text] [Related]
15. Economic impact of early intervention in psychosis services: results from a longitudinal retrospective controlled study in England.
Tsiachristas A; Thomas T; Leal J; Lennox BR
BMJ Open; 2016 Oct; 6(10):e012611. PubMed ID: 27798015
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the costs of treating schizophrenia in Spain: a hierarchical Bayesian approach.
Vázquez-Polo FJ; Negrín M; Cabasés JM; Sánchez E; Haro JM; Salvador-Carulla L
J Ment Health Policy Econ; 2005 Sep; 8(3):153-65. PubMed ID: 16278503
[TBL] [Abstract][Full Text] [Related]
17. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
18. Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics.
Fitzgerald PB; Montgomery W; de Castella AR; Filia KM; Filia SL; Christova L; Jackson D; Kulkarni J
Aust N Z J Psychiatry; 2007 Oct; 41(10):819-29. PubMed ID: 17828655
[TBL] [Abstract][Full Text] [Related]
19. 'Earning and learning' in those with psychotic disorders: the second Australian national survey of psychosis.
Waghorn G; Saha S; Harvey C; Morgan VA; Waterreus A; Bush R; Castle D; Galletly C; Stain HJ; Neil AL; McGorry P; McGrath JJ
Aust N Z J Psychiatry; 2012 Aug; 46(8):774-85. PubMed ID: 22718112
[TBL] [Abstract][Full Text] [Related]
20. Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study.
de Graaff B; Neil A; Sanderson K; Yee KC; Palmer AJ
Aust Health Rev; 2017 Jul; 41(3):254-267. PubMed ID: 27444148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
